← All companies ← SSD Manual SSNC → ← SOLV Medical Devices & Equipment STAA →
SSII, SS Innovations International Inc.
We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies.
We design, manufacture and market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the " SSi Mantra ") intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries.
While surgical robotic systems have gained acceptance globally in the past two decades for providing greater efficiency, better clinical outcomes and reducing healthcare costs, access to such systems remains largely limited to developed countries such as the United States (the " U.S.
The business
What it sells, where the money comes from, the kind of company it is.
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- Situation
- Unprofitable. No meaningful revenue yet; the record is the cash on hand against the burn.
- What moves the needle
- Operating margin has run around −206% through the cycle on a 12% gross margin, the operating line deeply negative — so the lever is the path to a margin at all: revenue growth against the cost curve and the cash runway, not the level of a margin that isn't there yet. Stock-based pay runs about 60% of sales, a real and recurring claim on owners that the GAAP margin understates. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on litigation & contingencies, set against the numbers in what the filing emphasizes, below.
- Is it a good business?
- Return on capital has rarely cleared the cost of capital (median −86%, above 15% in 0 of 3 years). Owner earnings, the cash-based check, have been thin too. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.
Every line is arithmetic on the company's filings, shown in full in the sections below.
The record
Ten years of arithmetic, read across the cycle.
The record, 2022–2025
realized figures from each filing · older years to the left| 2022’22 | 2023’23 | 2024’24 | 2025’25 | TTMTTMMar 2026 | |
|---|---|---|---|---|---|
| Income statement | |||||
| $1M | $6M | $21M | $42M | $48M | RevenueRevenue |
| 4% | 12% | 41% | 46% | 49% | Gross marginGross mgn |
| 135% | 171% | 49% | 35% | 33% | SG&A / revenueSG&A/rev |
| 69% | 18% | 12% | 9% | 8% | R&D / revenueR&D/rev |
| ($3M) | ($20M) | ($19M) | ($8M) | ($6M) | Operating incomeOp. inc. |
| −206.0% | −345.1% | −91.9% | −19.3% | −12.2% | Operating marginOp. mgn |
| ($3M) | ($21M) | ($19M) | ($12M) | ($10M) | Net incomeNet inc. |
| Cash flow & returns | |||||
| ($6M) | ($15M) | ($10M) | ($19M) | ($15M) | Operating cash flowOp. cash |
| $97K | $153K | $436K | $1M | $1M | DepreciationDeprec. |
| ($4M) | ($4M) | ($5M) | ($16M) | ($15M) | Working capital & otherWC & other |
| $220K | $453K | $661K | $4M | $3M | CapexCapex |
| 15.3% | 7.7% | 3.2% | 8.6% | 5.9% | Capex / revenueCapex/rev |
| ($6M) | ($16M) | ($10M) | ($20M) | ($16M) | Owner earningsOwner earn. |
| −424.1% | −264.1% | −48.1% | −46.2% | −32.9% | Owner earnings marginOE mgn |
| ($6M) | ($16M) | ($10M) | ($22M) | ($18M) | Free cash flowFCF |
| −432.7% | −269.2% | −49.2% | −52.3% | −36.3% | Free cash flow marginFCF mgn |
| — | -86% | -115% | -18% | -12% | ROICROIC |
| — | -106% | -142% | -32% | -18% | Return on equityROE |
| — | −106% | −142% | −32% | −18% | Retained to equityRetained/eq |
| Balance sheet | |||||
| $217K | $2M | $467K | $3M | $16M | Cash & investmentsCash+inv |
| $157K | $2M | $4M | $12M | $14M | ReceivablesReceiv. |
| $904K | $7M | $10M | $17M | $17M | InventoryInvent. |
| $165K | $902K | $2M | $5M | $4M | Accounts payablePayables |
| $895K | $8M | $12M | $24M | $27M | Operating working capitalOper. WC |
| $4M | $21M | $27M | $49M | $66M | Current assetsCur. assets |
| $8M | $8M | $21M | $26M | $26M | Current liabilitiesCur. liab. |
| 0.5× | 2.5× | 1.3× | 1.9× | 2.5× | Current ratioCurr. ratio |
| $7M | $32M | $42M | $74M | $91M | Total assetsAssets |
| $590K | $1M | $75K | $189K | $1M | Total debtDebt |
| $373K | ($1M) | ($392K) | ($3M) | ($15M) | Net debt / (cash)Net debt |
| -18.3× | -38.7× | -19.5× | -7.4× | -5.8× | Interest coverageInt. cov. |
| ($3M) | $20M | $13M | $38M | $55M | Shareholders’ equityEquity |
| 60.3% | 165.5% | 69.5% | 19.1% | 18.3% | Stock comp / revenueSBC/rev |
| Per share | |||||
| 128M | 152M | 181M | 199M | 205M | Shares out (diluted)Shares |
| $0.01 | $0.04 | $0.11 | $0.21 | $0.24 | Revenue / shareRev/sh |
| $-0.03 | $-0.14 | $-0.11 | $-0.06 | $-0.05 | EPS (diluted)EPS |
| $-0.05 | $-0.10 | $-0.05 | $-0.10 | $-0.08 | Owner earnings / shareOE/sh |
| $-0.05 | $-0.10 | $-0.06 | $-0.11 | $-0.09 | Free cash flow / shareFCF/sh |
| $0.00 | $0.00 | $0.00 | $0.02 | $0.01 | Cap. spending / shareCapex/sh |
| $-0.02 | $0.13 | $0.07 | $0.19 | $0.27 | Book value / shareBVPS |
| 3-yr | 5-yr | |
|---|---|---|
| Revenue / share | +167.2%/yr | +167.2%/yr (3-yr) |
| Capital spending / share | +120.4%/yr | +120.4%/yr (3-yr) |
The record, charted
FY2022–2025Each measure over its full record; the current point and the worst year marked.
Owner earnings vs. net income
Owner earningsNet incomeThe accountant's number, and the cash an owner can take; the gap is the tell.
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2025 the business earned ($20M) of owner earnings, the operating cash left after the $1M it takes just to hold its position. It put $3M more into growth; free cash flow, after that spending, was ($22M).
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Reported net income | ($12M) | ($19M) | ($21M) | ($3M) |
| Depreciation & amortizationnon-cash charge added back | +$1M | +$436K | +$153K | +$97K |
| Stock-based compensationreal costnon-cash, but a real cost | +$8M | +$14M | +$10M | +$865K |
| Working capital & othertiming of cash in and out, other non-cash items | −$16M | −$5M | −$4M | −$4M |
| Cash from operations | ($19M) | ($10M) | ($15M) | ($6M) |
| Maintenance capital expenditurethe spending needed just to hold position and volume | −$1M | −$436K | −$153K | −$97K |
| Owner earnings | ($20M) | ($10M) | ($16M) | ($6M) |
| Growth capital expenditurediscretionary; spent to get bigger, not to stand still | −$3M | −$225K | −$301K | −$124K |
| Free cash flow | ($22M) | ($10M) | ($16M) | ($6M) |
| Owner-earnings marginowner earnings ÷ revenue | -46% | -48% | -264% | -424% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the maintenance capital it must spend to hold its position (here about $1M, roughly its depreciation, the rate its assets wear out). The other $3M of its capital spending is growth it chose, not upkeep it owed; charged only with the maintenance it must do, the business earns well more than the year's free cash flow shows. The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $8M), owner earnings is nearer ($28M).
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- Can it pay its interest? -7.4×Does not cover its interestOperating income ($8M) ÷ interest expense $1M
What this means
A full year of operating profit didn't cover the interest bill. This is the zombie zone: the business depends on refinancing, asset sales, or forbearance to service its debt.
- Net cashCash $3M − debt $1M
What this means
Cash and short-term investments exceed every dollar of debt by $2M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Long (60+ days)DSO 107 + DIO 272 − DPO 82 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.
Is it a good business?
- Below average through the cycle3-yr median, range -115%–-18%; -18% latest = NOPAT ($6M) ÷ invested capital $36MIndustry peers: median -16%
What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 3 years (it ran -18% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
- Owner-earnings margin -264%Consumes cash through the cycle4-yr median margin, range -424%–-46%; latest ($20M) = operating cash ($19M) − maintenance capex $1MIndustry peers: median -25%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -46% of revenue this year, a -264% median across 4 years. It chose to put $3M more into growth, so free cash flow this year was ($22M) — the gap is investment, not weakness. Treating stock comp as the real expense it is (less $8M of SBC) leaves ($28M).
- Are earnings backed by cash? ($19M)Loss, and burning cashNet income ($12M) · cash from operations ($19M)
What this means
The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did not.
How is the cash used?
- No surplus to allocate
What this means
The business didn't generate positive Owner Earnings this year, so any distributions came from the balance sheet or borrowing, not from operations.
- Investing or harvesting? 3.40×ExpandingCapex $4M ÷ depreciation $1M
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
Graham’s defensive tests · 1 of 3 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size MissRevenue ≥ $2B · $42M
What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
- Strong liquidity NearCurrent ratio ≥ 2× · 1.86×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Conservative debt PassDebt ≤ working capital · $1M vs $23M WC
What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-0.09/share (latest year $-0.06), the averaged base the calculator's gate runs on, and book value is $0.19/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Durability & moat, 2022–2025
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 0 of 4
What this means
Lost money in 4 year(s), look at what happened there before trusting the average.
- Return on capital ≥ 15% 0 of 3 yrs
What this means
A moat shows up as a high return on invested capital that holds year after year, not one good vintage.
- Operating margin −276% → −56% (2-yr avg ends)
What this means
Through the cycle the operating margin widened — about −276% early to −56% lately, median −206% — pricing power intact or improving.
- Reinvestment, incremental ROIC returns capital
What this means
The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.
- Worst year 2023 · −345.1% op. margin
What this means
Operations went underwater in 2023, understand why before trusting the good years.
- Share count +15.7%/yr
What this means
The share count is rising, dilution works against you on a per-share basis.
Does AI threaten the moat?
Low contestabilityThe moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.
The filing positions AI as something the company uses, not something it fears.
“SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities with Mixed Reality (XR) and AI enabled technologies including the following: SSi Guru .”
AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat, and the company is using it that way.
Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.
All figures as filed; the source filing is linked above.
Current Position
as of the latest quarter, Mar 31, 2026Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments$16M
- Receivables$14M
- Inventory$17M
- Other current assets$19M
- Debt due within a year$522K
- Accounts payable$4M
- Other current liabilities$21M
From the company's latest filing.
Management, ownership & pay
From the proxy: how much of the business the people running it own, and how they are paid.
- Stock-based compensation$8M
The slice of the business handed to employees in shares this year, 19% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.
Peers, Medical Devices & Equipment
The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.
| Company | Revenue | Gross margin | Op. margin | ROIC | Owner earn. margin |
|---|---|---|---|---|---|
| BFLYButterfly Network Inc. | $98M | 37% | -263.0% | -134% | -179% |
| BLFSBioLife Solutions Inc. | $96M | 66% | -9.6% | -3% | 4% |
| KMTSKestra Medical Technologies Ltd. | $95M | 40% | -177.8% | -53% | -143% |
| IRMDiRadimed Corporation | $84M | 77% | 26.4% | 51% | 25% |
| FOCLEDAP TMS S.A. | $71M | 43% | -35.0% | -115% | -25% |
| APTAlpha Pro Tech Ltd. | $59M | 38% | 6.7% | 9% | 6% |
| SIShoulder Innovations Inc. | $47M | 77% | -55.6% | -16% | -67% |
| SSIISS Innovations International Inc. | $42M | 27% | -149.0% | -86% | -156% |
| Group median | — | 42% | -45.3% | -34% | -46% |
The price
What a price has to assume.
What the price implies
reverse-DCFSS Innovations International Inc. is profitable, but owner earnings are negative this year because capital spending currently outruns operating cash, a build-out, so the owner-earnings reverse-DCF has no positive base to grow. We read the price from both ends instead: type a price to see the steady-state profitability it demands, then set the mature margin you would believe and weigh the two against each other. Nothing leaves your browser unless you enter it in your notebook.
Enter a price to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Two reads of one future. From your price: the owner earnings the company must reach, valued at a mature multiple and discounted back at your rate, expressed as the margin it implies on revenue grown at your rate. From your belief: the mature margin you would credit, set on the dial above. When the margin the price demands runs above the one you would believe, you are paying for a future taken on faith. For a deep cyclical at a trough, normalized through-cycle earnings are the better lens; this mode is for the genuinely unprofitable, and for the profitable business whose capital spending currently outruns its cash.
Manual order: ← SSD its page in the Manual SSNC →
Industry order: ← SOLV the Medical Devices & Equipment chapter STAA →